Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11 | Achieve Life Sciences Inc (ACHV) | XNAS | US | 2023-12-31 | 2 days ago | USD | 4.56 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
12 | Acacia Communications Inc (ACIA) | 2019-12-31 | 3 years ago | USD | 0.00 | 16.34 | 0.00% | 8.18 | 0.00% | NCAV (Net-Net) | 8.18 | 0.00% | ||
13 | AC Immune SA (ACIU) | XNAS | CH | 2023-12-31 | 2 days ago | CHF | 0.00 | 0.00 | 0.00% | 1.04 | 0.00% | Ungraded | 0.00 | 0.00% |
14 | Acorda Therapeutics Inc (ACOR) | XNAS | US | 2022-12-31 | 4 months ago | USD | 1.35 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
15 | Aclaris Therapeutics Inc (ACRS) | XNAS | US | 2023-12-31 | 2 days ago | USD | 1.19 | 0.00 | 0.00% | 1.25 | 105.06% | Ungraded | 0.00 | 0.00% |
16 | AcelRx Pharmaceuticals Inc (ACRX) | XNAS | US | 2022-12-31 | 7 months ago | USD | 0.99 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
17 | Adaptimmune Therapeutics PLC (ADAP) | XNAS | GB | 2023-12-31 | 2 days ago | USD | 1.24 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
18 | Adial Pharmaceuticals Inc (ADIL) | XNAS | US | 2023-12-31 | 2 days ago | USD | 0.99 | 0.00 | 0.00% | 1.54 | 155.17% | Ungraded | 0.00 | 0.00% |
19 | ADMA Biologics Inc (ADMA) | XNAS | US | 2023-12-31 | 2 days ago | USD | 17.35 | 0.00 | 0.00% | 0.28 | 1.61% | NCAV (Net-Net) | 0.28 | 1.61% |
20 | Adamis Pharmaceuticals Corp (ADMP) | XNAS | US | 2022-12-31 | 11 months ago | USD | 0.78 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |